Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

Maximilian Y. Deng, Martin Sill, Jason Chiang, Jens Schittenhelm, Martin Ebinger, Martin U. Schuhmann, Camelia Maria Monoranu, Till Milde, Andrea Wittmann, Christian Hartmann, Clemens Sommer, Werner Paulus, Jutta Gärtner, Wolfgang Brück, Thomas Rüdiger, Alfred Leipold, Zane Jaunmuktane, Sebastian Brandner, Felice Giangaspero, Paolo NozzaJaume Mora, Andres Morales la Madrid, Ofelia Cruz Martinez, Jordan R. Hansford, Torsten Pietsch, Anna Tietze, Pablo Hernáiz-Driever, Iris Stoler, David Capper, Andrey Korshunov, David W. Ellison, Andreas von Deimling, Stefan M. Pfister, Felix Sahm, David T.W. Jones

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features'. Together they form a unique fingerprint.

Medicine & Life Sciences